Author: Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, Omel JL, Rainey JM, Rebulla P, Rowley SD, Troner MB, Anderson KC
Year: 2017
AGREE II score: Available
Developer organization: American Society of Clinical Oncology
Type of cancer: Not disease site specific
Patient population: Adult, Pediatric
Location: International
This is a clinical practice guideline for adults and children with hematologic malignancies, solid tumours, or hypoproliferative thrombocytopenia. The guideline examines when and how clinicians should use platelet transfusion to prevent or manage bleeding in these patients. Recommendations are made on topics such as the preparation of platelet products, the prevention of Rhesus (Rh) alloimmunization, and platelet transfusion thresholds for patients with different conditions.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 91.7%
Applicability: 47.9%
Stakeholder involvement: 72.2%
Editorial independence: 45.8%
Rigour: 79.2%
Clarity presentation: 86.1%